Page 138 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 9 Hematopoietic Stem Cell Biology 109

Aifantis I, Raetz E, Buonamici S: Molecular pathogenesis of T-cell leukaemia
and lymphoma. Nat Rev Immunol 8:380, 2008.
Baylin SB, Jones PA: A decade of exploring the cancer epigenome–biological
and translational implications. Nat Rev Cancer 11:726–734, 2011.
Beerman I, Rossi DJ: Epigenetic control of stem cell potential during homeo-
stasis, aging, and disease. Cell Stem Cell 16:613–625, 2015.
Bertrand JY, Chi NC, Santoso B, et al: Haematopoietic stem cells derive
directly from aortic endothelium during development. Nature 464:108–
A 111, 2010.
Blank U, Karlsson G, Karlsson S: Signaling pathways governing stem-cell
fate. Blood 111:492–503, 2008.
Chen CW, Armstrong SA: Targeting DOT1L and HOX gene expression in
MLL-rearranged leukemia and beyond. Exp Hematol 43:673–684, 2015.
Chen MJ, Yokomizo T, Zeigler BM, et al: Runx1 is required for the
endothelial to haematopoietic cell transition but not thereafter. Nature
457:887–891, 2009.
Cheng CW, Adams GB, Perin L, et al: Prolonged fasting reduces IGF-1/
PKA to promote hematopoietic-stem-cell-based regeneration and reverse
immunosuppression. Cell Stem Cell 14:810–823, 2014.
Dahlberg A, Delaney C, Bernstein ID: Ex vivo expansion of human hemato-
B poietic stem and progenitor cells. Blood 117:6083–6090, 2011.
Delaney C, Heimfeld S, Brashem-Stein C, et al: Notch-mediated expansion
Fig. 9.4 CLONAL DYNAMICS IN HEMATOLOGIC MALIGNAN- of human cord blood progenitor cells capable of rapid myeloid reconstitu-
CIES. (A) The cancer stem cell (CSC) model assumes a hierarchical structure tion. Nat Med 16:232–236, 2010.
akin the normal hematopoietic hierarchy. The CSC can give rise to the Doan PL, Himburg HA, Helms K, et al: Epidermal growth factor regulates
hematopoietic lineage but usually results in a differentiation block leading to hematopoietic regeneration after radiation injury. Nat Med 19:295–304,
the accumulation of immature progenitor (blast) cells. (B) The clonal evolu- 2013.
tion model suggests that a carcinogen-induced change in a normal cell confers Doulatov S, Vo LT, Chou SS, et al: Induction of multipotential hematopoi-
a growth advantage to that cell permitting its clonal expansion. Selective etic progenitors from human pluripotent stem cells via respecification of
pressures are responsible for some mutant subclones to expand while others lineage-restricted precursors. Cell Stem Cell 13:459–470, 2013.
become extinct or dormant. A combination of both models is also possible. Dykstra B, Kent D, Bowie M, et al: Long-term propagation of distinct
(A, Adapted from Wang J, Ma Y, Cooper MK: Cancer stem cells in glioma: challenges hematopoietic differentiation programs in vivo. Cell Stem Cell 1:218–229,
and opportunities. Transl Cancer Res 2, 429, 2013. B, Adapted from Greaves M, 2007.
Maley CC: Clonal evolution in cancer. Nature 481, 306, 2012; Nowell PC: The Dzierzak E, Speck NA: Of lineage and legacy: the development of mam-
clonal evolution of tumor cell populations. Science 194, 23, 1976.) malian hematopoietic stem cells. Nat Immunol 9:129–136, 2008.
Eaves CJ: Hematopoietic stem cells: concepts, definitions, and the new reality.
Blood 125:2605–2613, 2015.
Fares I, Chagraoui J, Gareau Y, et al: Cord blood expansion. Pyrimidoindole
An additional driver mutation occurring in this clone then gives rise derivatives are agonists of human hematopoietic stem cell self-renewal.
287
to the founding LSC. Mutations in either the LSC itself or again its Science 345:1509–1512, 2014.
526
subclones can evolve into the dominating clone in relapsed AML. Fatica A, Bozzoni I: Long non-coding RNAs: new players in cell differentia-
Genomic profiling of AML patients has yielded strong evidence for the tion and development. Nat Rev Genet 15:7–21, 2014.
presence of nonmalignant preleukemic HSPCs 286,346,530 that survive Golub R, Cumano A: Embryonic hematopoiesis. Blood Cells Mol Dis
chemotherapy and produce mature lymphoid cells while at the same 51:226–231, 2013.
time generating new waves of mutant clones as the disease progresses. Greaves M, Maley CC: Clonal evolution in cancer. Nature 481:306–313,
Mutations in epigenetic genes, for instance, DNMT3A, IDH2 and 2012.
ASXL1, are often identified in the ancestral clones, suggesting their Greenblatt SM, Nimer SD: Chromatin modifiers and the promise of epigen-
early role in AML pathogenesis, whereas mutations in NPM1 and etic therapy in acute leukemia. Leukemia 28:1396–1406, 2014.
signaling genes appear to be acquired later. 286,346 Of note, DNMT3A Guo G, Luc S, Marco E, et al: Mapping cellular hierarchy by single-cell
and ASXL1 are also among the three most recurrently mutated analysis of the cell surface repertoire. Cell Stem Cell 13:492–505, 2013.
genes in clonal hematopoiesis (along with TET2) and present with Gurumurthy S, Xie SZ, Alagesan B, et al: The Lkb1 metabolic sensor
a frequency of about 10% of healthy people over 65 years. 531,532 maintains haematopoietic stem cell survival. Nature 468:659–663,
Furthermore, these findings indicate that the LSC crucial for driving 2010.
the progression to AML can be a downstream progenitor (in this Himburg HA, Muramoto GG, Daher P, et al: Pleiotrophin regulates the
case, a GMP and/or multilymphoid progenitor). Further support expansion and regeneration of hematopoietic stem cells. Nat Med
comes from mouse models: LSCs from leukemias initiated by forced 16:475–482, 2010.
expression of an MLL-AF9 fusion gene (common in AML patients) Ito K, Carracedo A, Weiss D, et al: A PML-PPAR-delta pathway for fatty
in GMPs retain the identity of the progenitor cells, despite having acid oxidation regulates hematopoietic stem cell maintenance. Nat Med
324
acquired self-renewal potential. The identification of both tumor- 18:1350–1358, 2012.
initiating ancestral HSPCs and LSCs has important implications for Jamieson CH, Ailles LE, Dylla SJ, et al: Granulocyte-macrophage progenitors
the treatment of hematologic malignancies, as relapse-causing clones as candidate leukemic stem cells in blast-crisis CML. N Engl J Med
may be unrelated to the predominant clones at diagnosis in ~50% of 351:657–667, 2004.
patients with B-cell acute lymphoblastic leukemia (B-ALL), T-ALL Keller G: Embryonic stem cell differentiation: emergence of a new era in
and AML. 346 biology and medicine. Genes Dev 19:1129–1155, 2005.
Kiel MJ, Yilmaz OH, Iwashita T, et al: SLAM family receptors distinguish
hematopoietic stem and progenitor cells and reveal endothelial niches for
SUGGESTED READINGS stem cells. Cell 121:1109–1121, 2005.
Ling H, Fabbri M, Calin GA: MicroRNAs and other non-coding RNAs
Adams PD, Jasper H, Rudolph KL: Aging-induced stem cell mutations as as targets for anticancer drug development. Nat Rev Drug Discov
drivers for disease and cancer. Cell Stem Cell 16:601, 2015. 12:847–865, 2013.